用SCAR-Q评估瘢痕疙瘩治疗后的症状与心理社会福祉
本研究通过电话联系瘢痕疙瘩门诊患者,比较治疗前后SCAR-Q三个部分(外观、症状、心理社会影响)及疼痛、瘙痒评分。60例患者中完成术前35份、术后34份问卷,治疗后疼痛、瘙痒及SCAR-Q三部分均显著改善(P<0.001)。作者认为瘢痕疙瘩治疗可显著改善症状与心理社会负担。
要点
- 治疗后疼痛均值从5.6降至0.1(P<0.001),瘙痒从6.5降至0.8(P<0.001)。
- SCAR-Q外观从26.5升至73.4,症状从44.0升至81.4,心理社会影响从27.7升至82.6(均P<0.001)。
- 瘢痕疙瘩治疗方案尚未确立,但作者认为不应忽视治疗对患者福祉的益处。
核心结论
- 瘢痕疙瘩患者治疗后症状与心理社会负担显著改善。
- 尽管瘢痕疙瘩的治疗方式尚未确立,作者认为整形外科医生不应忽视治疗对患者福祉的益处。
研究设计与样本
- 研究纳入瘢痕疙瘩门诊术前和术后患者,通过电话联系。
- 记录人口学信息、瘢痕疙瘩特征及疼痛、瘙痒水平,并完成SCAR-Q全部3个部分(外观、症状、心理社会影响)。
- 60例患者参与,完成术前问卷35份、术后问卷34份。
- 统计分析采用SPSS 23版(IBM Corp.,Armonk,NY)。
主要发现
- 疼痛均值(标准差)从5.6(4.0)降至0.1(0.4),P<0.001。
- 瘙痒均值(标准差)从6.5(3.0)降至0.8(1.5),P<0.001。
- SCAR-Q外观从26.5(22.3)升至73.4(23.0),P<0.001。
- SCAR-Q症状从44.0(15.7)升至81.4(16.7),P<0.001。
- SCAR-Q心理社会影响从27.7(30.7)升至82.6(26.3),P<0.001。
关键数值与推荐
- 疼痛均值(标准差)从5.6(4.0)降至0.1(0.4),P<0.001。
- 瘙痒均值(标准差)从6.5(3.0)降至0.8(1.5),P<0.001。
- SCAR-Q外观从26.5(22.3)升至73.4(23.0),P<0.001。
- SCAR-Q症状从44.0(15.7)升至81.4(16.7),P<0.001。
- SCAR-Q心理社会影响从27.7(30.7)升至82.6(26.3),P<0.001。
临床怎么用
- 作者认为,尽管瘢痕疙瘩治疗方式尚未确立,整形外科医生不应忽视治疗对患者福祉的益处。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many patients with keloids experience symptoms, such as pain and pruritus, and may present with significant psychosocial burdens. However, no single therapeutic regimen has been firmly established for treatment of keloids. OBJECTIVES: The aim of this study was to assess patients' perspectives on their keloids after treatment by comparing preoperative and postoperative surveys. METHODS: All patients seen at the keloid clinic, both preoperatively and postoperatively, were contacted by telephone call. Information about demographics, keloid characteristics, and levels of pain and pruritus were recorded. Participants also completed all 3 parts (appearance, symptoms, and psychosocial impact) of the SCAR-Q, a validated patient-reported outcome measure questionnaire. Statistical analysis was performed with SPSS version 23 (IBM Corp., Armonk, NY). RESULTS: Of the 60 patients who participated in the study, 35 preoperative and 34 postoperative surveys were completed. Patients experienced significant reductions in mean [standard deviation] pain levels (from 5.6 [4.0] to 0.1 [0.4], P < 0.001) and pruritus (from 6.5 [3.0] to 0.8 [1.5], P < 0.001) postintervention. Significant improvements in all 3 parts of the SCAR-Q were noted. Appearance improved from 26.5 [22.3] to 73.4 [23.0] (P < 0.001); symptoms from 44.0 [15.7] to 81.4 [16.7] (P < 0.001); and psychosocial impact from 27.7 [30.7] to 82.6 [26.3] (P < 0.001). CONCLUSIONS: Patients with keloids experience significant improvement in their symptomatic and psychosocial burden after treatment. Although management modalities are not well established, it is essential that plastic surgeons do not overlook the therapeutic benefits for their patients' well-being.
引用
- Kim M, Mirsky N, Spielman A, et al. Evaluating Symptomatic and Psychosocial Well-being After Keloid Treatment With SCAR-Q. Aesthet Surg J. 2022. PMID: 35224618. doi:10.1093/asj/sjac043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。